Accipiter Capital Management as of March 31, 2011
Portfolio Holdings for Accipiter Capital Management
Accipiter Capital Management holds 22 positions in its portfolio as reported in the March 2011 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
WellPoint | 13.7 | $17M | 250k | 69.79 | |
Aetna | 9.8 | $13M | 336k | 37.43 | |
Sanofi-Aventis SA (SNY) | 7.5 | $9.6M | 273k | 35.22 | |
Hca Holdings (HCA) | 7.0 | $8.9M | 263k | 33.87 | |
Orchid Cellmark | 6.2 | $7.9M | 3.9M | 2.01 | |
Gilead Sciences (GILD) | 5.5 | $7.0M | 165k | 42.47 | |
RehabCare | 5.3 | $6.8M | 186k | 36.87 | |
Express Scripts | 4.5 | $5.8M | 104k | 55.61 | |
BioMarin Pharmaceutical (BMRN) | 4.5 | $5.8M | 230k | 25.13 | |
Health Management Associates | 4.5 | $5.7M | 522k | 10.90 | |
Coventry Health Care | 3.9 | $5.0M | 156k | 31.86 | |
Quest Diagnostics Incorporated (DGX) | 3.8 | $4.9M | 85k | 57.72 | |
Medco Health Solutions | 3.8 | $4.8M | 86k | 56.17 | |
Medicis Pharmaceutical Corporation | 3.3 | $4.2M | 131k | 32.04 | |
CIGNA Corporation | 3.2 | $4.1M | 93k | 44.28 | |
American Medical Systems Holdings | 3.1 | $4.0M | 184k | 21.64 | |
RTI Biologics | 2.8 | $3.6M | 1.3M | 2.86 | |
Healthsouth | 2.5 | $3.2M | 127k | 24.98 | |
Obagi Medical Products | 2.3 | $3.0M | 236k | 12.64 | |
Cleveland Biolabs Inc Cmn Stk cmn | 1.3 | $1.6M | 3.1k | 529.58 | |
Service Corporation International (SCI) | 1.1 | $1.4M | 128k | 11.06 | |
Biotime Inc put | 0.3 | $449k | 1.3k | 340.15 |